Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis

被引：0
|
作者：
J. Hillengass
A. D. Ho
H. Goldschmidt
R. Waldherr
T. M. Moehler
机构：
[1] University Hospital of Heidelberg,Department of Hematology, Oncology and Rheumatology
[2] Gemeinschaftspraxis Pathologie,undefined
来源：
International Journal of Hematology | 2008年 / 88卷
关键词：
Cryoglobulinemia; Multiple myeloma; Stem cell transplantation; Immune reset;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We present a case report of a patient with cryoglobulin-vasculitis caused by multiple myeloma in Durie/Salmon stage I refractory to conventional therapy modalities treated with high-dose chemotherapy followed by autologous blood stem cell transplantation. While clinical symptoms of vasculitis disappeared, elevated cryoglobulin levels persisted. Therefore we conclude that the relief of symptoms was caused by an immunomodulation induced by the autologous stem cell transplantation.
引用
收藏
页码：454 / 456
页数：2
相关论文
共 50 条
  • [31] Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients
    Martino, Massimo
    Pratio, Giulia
    Messina, Giuseppe
    Irrera, Giuseppe
    Massara, Elisabetta
    Messina, Giuseppe
    Console, Giuseppe
    Iacopino, Pasquale
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (05) : 410 - 415
  • [32] Clinical and histological responses of renal amyloidosis to high-dose melphalan supported by autologous stem cell transplantation
    Sanada, Satoru
    Suzuki, Masayuki
    Shindo, Tetsuro
    Suzuki, Saya
    Nakamichi, Takashi
    Matsubara, Mitsunobu
    Maeda, Kunihiko
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (02) : 747 - 750
  • [33] High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis
    Sanchorawala, Vaishali
    ACTA HAEMATOLOGICA, 2020, 143 (04) : 381 - 387
  • [34] Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma
    Byun, Ja Min
    Lee, Jayoun
    Shin, Sang-Jin
    Kang, Minjoo
    Yoon, Sung-Soo
    Koh, Youngil
    BLOOD RESEARCH, 2018, 53 (02) : 105 - 109
  • [35] Comparison of conditioning regimen toxicities among autologous stem cell transplantation eligible multiple myeloma patients: High-dose melphalan versus high-dose melphalan and bortezomib
    Aypar, Eda
    Izzettin, Fikret Vehbi
    Aki, Sahika Zeynep
    Sancar, Mesut
    Yegin, Zeynep Arzu
    Turkoz-Sucak, Gulsan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (04) : 281 - 289
  • [36] Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma
    Malard, Florent
    Battipaglia, Giorgia
    Gaugler, Beatrice
    Siblany, Lama
    van de Wyngaert, Zoe
    Bonnin, Agnes
    Dulery, Remy
    Banet, Anne
    Stocker, Nicolas
    Ricard, Laure
    Brissot, Eolia
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2023, 58 (11) : 1275 - 1278
  • [37] Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma
    Florent Malard
    Giorgia Battipaglia
    Béatrice Gaugler
    Lama Siblany
    Zoe van de Wyngaert
    Agnes Bonnin
    Rémy Duléry
    Anne Banet
    Nicolas Stocker
    Laure Ricard
    Eolia Brissot
    Mohamad Mohty
    Bone Marrow Transplantation, 2023, 58 : 1275 - 1278
  • [38] High-dose melphalan with BCNU and etoposide as preparative regimen for autologous hemopoietic stem cell transplantation in multiple myeloma (MM)
    Bernasconi, P
    Alessandrino, EP
    Colombo, AA
    Caldera, D
    Bonfichi, M
    Martinelli, G
    Malcovati, L
    Varettoni, M
    Maiocchi, M
    Brusamolino, E
    Pagnucco, G
    Castagnola, C
    Corso, A
    Bernasconi, C
    BONE MARROW TRANSPLANTATION, 1999, 23 : S133 - S133
  • [39] Arsenic trioxide with ascorbic acid and high-dose melphalan for autologous hematopoietic stem cell transplantation for multiple myeloma.
    Qazilbash, Muzaffar H.
    Saliba, Rima M.
    Davis, Marilyn S.
    Mendoza, Floralyn L.
    Hosing, Chitra
    Couriel, Daniel R.
    De Lima, Marcos
    Kebriaei, Partow
    Weber, Donna M.
    Wang, Michael
    Alousi, Arnin M.
    Matthes, Steven G.
    Jones, Roy B.
    Champlin, Richard E.
    Giralt, Sergio A.
    BLOOD, 2006, 108 (11) : 881A - 881A
  • [40] Phagocyte function decreases after high-dose treatment with melphalan and autologous stem cell transplantation in patients with multiple myeloma
    Wichert, Stina
    Pettersson, Asa
    Hellmark, Thomas
    Johansson, Asa
    Hansson, Markus
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (05) : 342 - 351
12345